Page last updated: 2024-09-03

medica 16 and Compensatory Hyperinsulinemia

medica 16 has been researched along with Compensatory Hyperinsulinemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Atkinson, LL; Bar-Tana, J; Kelly, SE; Lopaschuk, GD; Russell, JC	1

Other Studies

1 other study(ies) available for medica 16 and Compensatory Hyperinsulinemia

Article	Year
MEDICA 16 inhibits hepatic acetyl-CoA carboxylase and reduces plasma triacylglycerol levels in insulin-resistant JCR: LA-cp rats. Diabetes, 2002, Volume: 51, Issue:5 Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Hyperinsulinism; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Liver; Multienzyme Complexes; Muscle, Skeletal; Obesity; Palmitic Acids; Protein Serine-Threonine Kinases; Rats; Rats, Mutant Strains; Triglycerides	2002

Article

Year

MEDICA 16 inhibits hepatic acetyl-CoA carboxylase and reduces plasma triacylglycerol levels in insulin-resistant JCR: LA-cp rats.

Diabetes, 2002, Volume: 51, Issue:5

Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Hyperinsulinism; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Liver; Multienzyme Complexes; Muscle, Skeletal; Obesity; Palmitic Acids; Protein Serine-Threonine Kinases; Rats; Rats, Mutant Strains; Triglycerides

2002